RecruitingPhase 1NCT07289477

A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
iRegene Therapeutics Co., Ltd.
Intervention
Human Dopaminergic Progenitor Cells(biological)
Enrollment
9 enrolled
Eligibility
30-70 years · All sexes
Timeline
20252031

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07289477 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

See all trials for Multiple system atrophy

← Back to all trials